Quarterly report on Consolidated Results for The Financial Period Ended 31/12/2008
24 Feb 2009
 

    INDIVIDUAL PERIOD
    CUMULATIVE PERIOD
       
    CURRENT YEAR QUARTER
    PRECEDING YEAR
    CORRESPONDING
    QUARTER
    CURRENT YEAR TO DATE
    PRECEDING YEAR
    CORRESPONDING
    PERIOD
       
    31/12/2008
    31/12/2007
    31/12/2008
    31/12/2007
       
    RM'000
    RM'000
    RM'000
    RM'000
    1   Revenue
    29,484
    32,068
    122,872
    115,551
    2 Profit/(loss) before tax
    3,612
    11,384
    35,340
    42,587
    3 Profit/(loss) for the period
    3,517
    9,009
    27,403
    32,043
    4 Profit/(loss) attributable to ordinary equity holders of the parent
    3,517
    9,009
    27,403
    32,043
    5 Basic earnings/(loss) per share (sen)
    2.53
    6.49
    19.74
    23.09
    6 Proposed/Declared dividend per share (sen)
    7.00
    0.00
    15.00
    48.00








    AS AT END OF CURRENT QUARTER
    AS AT PRECEDING FINANCIAL YEAR END
    7
    Net assets per share attributable to ordinary equity holders of the parent (RM)
    0.9400
    0.8200


    Note: For full text of the above announcement, please access Bursa Malaysia website at www.bursamalaysia.com

     
     
      Solutions by WEBSEImportant legal information - please read the Privacy Policy & Disclaimer before proceeding.
    Copyright © 2010 CCM Duopharma Biotech Bhd. All Rights Reserved.